• Markets
  • icon
  • Companies
IIQ · ASX

Inoviq Ltd (ASX:IIQ)

AU$0.65

 0.07 (12.069%)
ASX:Live
15/04/2024 02:48:20 PM
Hammer Bearish HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

IIQ Overview

IIQ Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About IIQ

Website

Inoviq Ltd

Telephone

Address

Description

INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. It operates through the following geographical segments: Australia, United States of America, and Switzerland. The company was founded on June 30, 1983 and is headquartered in Subiaco, Australia.

IIQ Price Chart

Key Stats

Market Cap

AU$54.29M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.47 - 0.99

Trade Value (12mth)

AU$13,922.00

1 week

1.75%

1 month

1.75%

YTD

-14.07%

1 year

18.37%

All time high

61.1211

Key Fundamentals

EPS 3 yr Growth

36.000%

EBITDA Margin

%

Operating Cashflow

-$7m

Free Cash Flow Return

-28.70%

ROIC

-36.70%

Interest Coverage

-151.60

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

92m

HALO Sector

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IIQ Announcements

Latest Announcements

Date Announcements

15 April 24

INOVIQ and Promega sign Global EXO-NET Agreement

×

INOVIQ and Promega sign Global EXO-NET Agreement

12 April 24

INOVIQ ShareCafe Investor Presentation

×

INOVIQ ShareCafe Investor Presentation

20 March 24

INOVIQ expands exosome IP

×

INOVIQ expands exosome IP

19 March 24

Exosomes for non-invasive pre-natal testing

×

Exosomes for non-invasive pre-natal testing

23 February 24

Appendix 4D and FY24 Half Year Financial Report

×

Appendix 4D and FY24 Half Year Financial Report

22 February 24

Trading Halt

×

Trading Halt

22 February 24

INOVIQ detects 19% more breast cancers than leading test

×

INOVIQ detects 19% more breast cancers than leading test

31 January 24

Appendix 4C and Quarterly Activities Report - December 2023

×

Appendix 4C and Quarterly Activities Report - December 2023

11 December 23

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

11 December 23

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

11 December 23

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

11 December 23

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

01 December 23

Initial Director's Interest Notice (updated)

×

Initial Director's Interest Notice (updated)

01 December 23

Change in substantial holding

×

Change in substantial holding

01 December 23

2023 AGM Recording

×

2023 AGM Recording

30 November 23

Initial Director's Interest Notice

×

Initial Director's Interest Notice

29 November 23

2023 AGM CEO Presentation

×

2023 AGM CEO Presentation

29 November 23

2023 AGM Results of Meeting

×

2023 AGM Results of Meeting

16 November 23

Bell Potter Healthcare Conference Investor Presentation

×

Bell Potter Healthcare Conference Investor Presentation

08 November 23

ANSEV Meeting Presentations

×

ANSEV Meeting Presentations

03 November 23

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

30 October 23

Appendix 4C and Quarterly Activities Report - September 2023

×

Appendix 4C and Quarterly Activities Report - September 2023

27 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

11 October 23

INOVIQ Board expanded - David Williams to become Chairman

×

INOVIQ Board expanded - David Williams to become Chairman

27 September 23

Notice required under Listing Rule 3.13.1

×

Notice required under Listing Rule 3.13.1

IIQ Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.14 -0.20 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.14 -0.20 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -101.3 -38.8 51.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.06 -0.05 -0.08 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.07 -0.07 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.9 11.5 -44.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.9 -17.9 -9.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.36 0.31 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.04 0.18 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -74.4 397.0 -46.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 77 91 92 Lock Lock Lock
Basic m Lock Lock Lock Lock 77 91 92 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -40.9 43.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 7 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -3 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 45.4 44.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -736.7 -679.8 -261.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 837 780 361 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -6 -7 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -120.0 -10.5 -28.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,360.8 -2,542.3 -2,265.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -7 -9 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -151.5 -25.5 -14.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,555.2 -3,301.7 -2,615.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -15 -22 -10 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -3 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -11 -18 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -242.7 -63.2 50.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,382.2 -6,575.0 -2,252.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -6 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 3 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 17 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -6 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -124.0 -11.7 -15.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -12.1 -22.9 -18.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 5 15 8 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 31 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 -14 -7 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 29 28 20 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 30 29 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 362.9 -3.5 -30.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.3 -59.1 -41.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -39.6 -30.7 -42.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -61.2 -61.8 -36.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -28.9 -20.6 -28.7 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -64.2 -85.8 -151.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 2.0 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -12.9 -50.9 -36.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.9 9.7 6.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.8 9.7 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 88.5 88.1 83.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -360.5 -337.5 -462.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.9 0.3 0.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 164.9 70.8 92.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 129.2 368.5 117.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,133.8 -7,794.5 -2,527.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -43.8 -70.1 -46.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.3 -59.1 -41.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -38.4 -64.3 -45.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 2.2 5.2 4.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 93.9 1,269.7 1,328.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 96.2 1,274.9 1,332.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 64.6 139.6 188.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 31.5 1,135.3 1,144.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IIQ Shortsell

Frequently Asked Questions

The current share price of Inoviq Ltd (IIQ:ASX) is AU$0.65.
The 52-week high share price for Inoviq Ltd (IIQ:ASX) is AU$0.99.
The 52-week low share price for Inoviq Ltd (IIQ:ASX)? is AU$0.47.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) has a franking level of 0%.
Inoviq Ltd (IIQ:ASX) is classified in the Healthcare.
The current P/E ratio for Inoviq Ltd (IIQ:ASX) is .